Next Article in Journal
Dexamethasone Creates a Suppressive Microenvironment and Promotes Aspergillus fumigatus Invasion in a Human 3D Epithelial/Immune Respiratory Model
Next Article in Special Issue
Genomic Epidemiology of Candida auris in Qatar Reveals Hospital Transmission Dynamics and a South Asian Origin
Previous Article in Journal
Mold and Yeast-Like Fungi in the Seaside Air of the Gulf of Gdańsk (Southern Baltic) after an Emergency Disposal of Raw Sewage
Previous Article in Special Issue
Candida auris Whole-Genome Sequence Benchmark Dataset for Phylogenomic Pipelines
Brief Report

Emergence of Candida auris in Brazil in a COVID-19 Intensive Care Unit

Laboratório Especial de Micologia, Disciplina de Infectologia, Universidade Federal de São Paulo, São Paulo 04039-032, Brazil
Divisão de Laboratório Central, Hospital das Clínicas da Universidade de São Paulo, São Paulo 01246-100, Brazil
Instituto de Medicina Tropical, Universidade de São Paulo, São Paulo 01246-100, Brazil
Westerdijk Fungal Biodiversity Institute, 3508AD Utrecht, The Netherlands
Department of Medical Microbiology, University Medical Center Utrecht, 3584CS Utrecht, The Netherlands
Comissão de Controle de Infecção Hospitalar, Hospital de Bahia, Salvador 41810-011, Brazil
Laboratório Central de Saúde Pública Professor Gonçalo Muniz, Salvador 40295-010, Brazil
Centro de Informações Estratégicas de Vigilância em Saúde, Salvador 40279-120, Brazil
Agência Nacional de Vigilância Sanitária, Brasília 71205-050, Brazil
Coordenação Geral de Laboratórios de Saúde Pública, Ministério da Saúde, Brasília 70058-900, Brazil
Department of Medical Microbiology and Infectious Diseases, Canisius Wilhelmina Hospital (CWZ), 6532SZ Nijmegen, The Netherlands
Author to whom correspondence should be addressed.
Academic Editors: Anuradha Chowdhary and Jacques F. Meis
J. Fungi 2021, 7(3), 220;
Received: 24 February 2021 / Revised: 9 March 2021 / Accepted: 13 March 2021 / Published: 17 March 2021
(This article belongs to the Special Issue Candida auris 2.0)
In December 2020, Candida auris emerged in Brazil in the city of Salvador. The first two C. auris colonized patients were in the same COVID-19 intensive care unit. Antifungal susceptibility testing showed low minimal inhibitory concentrations of 1 µg/mL, 2 µg/mL, 0.03 µg/L, and 0.06 µg/mL for amphotericin B, fluconazole, voriconazole, and anidulafungin, respectively. Microsatellite typing revealed that the strains are clonal and belong to the South Asian clade C. auris. The travel restrictions during the COVID-19 pandemic and the absence of travel history among the colonized patients lead to the hypothesis that this species was introduced several months before the recognition of the first case and/or emerged locally in the coastline Salvador area. View Full-Text
Keywords: Candida auris; COVID-19; intensive care; Brazil Candida auris; COVID-19; intensive care; Brazil
Show Figures

Figure 1

MDPI and ACS Style

de Almeida, J.N., Jr.; Francisco, E.C.; Hagen, F.; Brandão, I.B.; Pereira, F.M.; Presta Dias, P.H.; de Miranda Costa, M.M.; de Souza Jordão, R.T.; de Groot, T.; Colombo, A.L. Emergence of Candida auris in Brazil in a COVID-19 Intensive Care Unit. J. Fungi 2021, 7, 220.

AMA Style

de Almeida JN Jr., Francisco EC, Hagen F, Brandão IB, Pereira FM, Presta Dias PH, de Miranda Costa MM, de Souza Jordão RT, de Groot T, Colombo AL. Emergence of Candida auris in Brazil in a COVID-19 Intensive Care Unit. Journal of Fungi. 2021; 7(3):220.

Chicago/Turabian Style

de Almeida, João N., Jr., Elaine C. Francisco, Ferry Hagen, Igor B. Brandão, Felicidade M. Pereira, Pedro H. Presta Dias, Magda M. de Miranda Costa, Regiane T. de Souza Jordão, Theun de Groot, and Arnaldo L. Colombo. 2021. "Emergence of Candida auris in Brazil in a COVID-19 Intensive Care Unit" Journal of Fungi 7, no. 3: 220.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

Back to TopTop